NCT06110624

Brief Summary

A study on the intent to use a tool (MuSt-PC) to manage symptoms of patients in a palliative care trajectory.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2024

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 7, 2023

Completed
24 days until next milestone

First Posted

Study publicly available on registry

October 31, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

April 18, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2025

Completed
Last Updated

November 25, 2025

Status Verified

October 1, 2025

Enrollment Period

11 months

First QC Date

October 7, 2023

Last Update Submit

November 20, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Questions evaluating Intention to Use (IU)

    Questions evaluating Intention to Use (IU) (7-point Likert scales)

    after 5 times use of the MuSt-PC tool within 3 months

Secondary Outcomes (6)

  • Questions evaluating other modified TAM domains

    after 5 times use of the MuSt-PC tool within 3 months

  • Perceived benefits and disadvantages of using MuSt-PC

    after 5 times use within 3 months

  • Suggestions to improve the MuSt-PC CDSS

    after 5 times of the MuSt-PC tool within 3 months

  • An overview of the content of questions of participating GHCPs regarding MuSt-PC use.

    after 5 times use within 3 months

  • Most useful elements of MuSt-PC will be evaluated with a multiple-choice question.

    after 5 times use within 3 months

  • +1 more secondary outcomes

Other Outcomes (1)

  • A focus group meeting will be conducted if ≥20% of all participating GHCPs have insufficient intention to use MuSt-PC and/or perceive MuSt-PC insufficiently useful and/or perceive MuSt-PC insufficiently easy to use

    after 5 times use of the MuSt-PC tool within 3 months

Study Arms (1)

Arm 1

A targeted sample of healthcare providers (HCPs) who are not specialized in palliative care (GHCPs) constitutes the study population.

Other: Survey

Interventions

SurveyOTHER

A survey study will be conducted to evaluate if GHCPs have the Intention to Use (IU) MuSt-PC in daily practice.

Arm 1

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

A targeted sample of healthcare providers (HCPs) who are not specialized in palliative care (GHCPs) constitutes the study population.

You may qualify if:

  • Residents (in Dutch: Arts In Opleiding tot Specialist (AIOS) or Arts Niet In Opleiding tot Specialist (ANIOS)), medical specialists and nurse practitioners working in the following disciplines are invited to participate:
  • General practice
  • Nursing home
  • Hospital:
  • Clinical geriatrics
  • Medical oncology
  • Radiation oncology
  • Pulmonology
  • Cardiology

You may not qualify if:

  • HCPs who were formally trained in palliative care ("kaderopleiding palliatieve zorg", "Masteropleiding Palliative Medicine for Health Care Professionals at Cardiff University" or "post-HBO opleiding palliatieve zorg") and/or who have been or are currently a consultant of a palliative care consultation team are considered specialists in palliative care, are excluded from participation.
  • GHCPs (e.g. nurses) who cannot independently decide about CDSS recommendation adherence, including drug interventions, are excluded from participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University Medical Center Groningen

Groningen, Netherlands

Location

LUMC

Leiden, Netherlands

Location

MeSH Terms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • An KL Reyners, MD, PhD

    University Medical Center Groningen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 7, 2023

First Posted

October 31, 2023

Study Start

April 18, 2024

Primary Completion

February 28, 2025

Study Completion

February 28, 2025

Last Updated

November 25, 2025

Record last verified: 2025-10

Locations